Alexander Hardy - 01 Dec 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Chief Executive Officer, Director
Signature: /s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 01 Dec 2023
Net transactions value: $0
Form type: 4
Filing time: 05 Dec 2023, 17:13:53 UTC
Next filing: 19 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Award	$0	+68,039		$0.000000	68,039	01 Dec 2023	Direct	F1
transaction	BMRN	Common Stock	Award	$0	+47,332	+70%	$0.000000	115,371	01 Dec 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to Buy Common Stock)	Award	$0	+150,529		$0.000000	150,529	01 Dec 2023	Common Stock	150,529	$92.42	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on December 1, 2023. Price not applicable.
F2	Option grant vests 12/48th on December 1, 2024 and 1/48th on the 1st day of each month thereafter.